Showing results (1161-1170 of 2,631) with videos related to
Sort By:
Pageof 264
Journal of Oncology|April 24, 2010
Molecular therapeutic targets for glioma angiogenesisShingo Takano, Toshiharu Yamashita, Osamu OhnedaJournal of Oncology|May 7, 2010
Precursor lesions of high-grade serous ovarian carcinoma: morphological and molecular characteristicsAmy L Gross, Robert J Kurman, Russell Vang, et al.Journal of Oncology|April 17, 2010
Phase II Study of Biweekly Pemetrexed Plus Irinotecan as Second-Line Therapy for Metastatic Colorectal CancerC Louvet, T André, E Gamelin, et al.Journal of Oncology|April 10, 2010
Cutaneous adenoid cystic carcinoma with perineural invasion treated by mohs micrographic surgery-a case report with literature reviewYaohui G Xu, Molly Hinshaw, B Jack Longley, et al.Journal of Oncology|August 1, 2009
Recent advances in image-guided radiotherapy for head and neck carcinomaSameer K Nath, Daniel R Simpson, Brent S Rose, et al.Journal of Oncology|March 5, 2009
Reinduction of bevacizumab in combination with pegylated liposomal Doxorubicin in a patient with recurrent glioblastoma multiforme who progressed on bevacizumab/irinotecanMohammed Almubarak, Michael Newton, Ramin AltahaJournal of Oncology|March 7, 2009
Strong expression of chemokine receptor CXCR4 by renal cell carcinoma correlates with advanced diseaseThomas C Wehler, Claudine Graf, Stefan Biesterfeld, et al.Journal of Oncology|March 12, 2009
Radiation therapy in addition to gross total resection of retroperitoneal sarcoma results in prolonged survival: results from a single institutional studyTimothy M Zagar, Robert R Shenk, Julian A Kim, et al.Journal of Oncology|March 12, 2009
Breast cancer biology: the multifaceted roles of mesenchymal stem cellsShyam A Patel, Andrew C Heinrich, Bobby Y Reddy, et al.Journal of Oncology|May 9, 2009
Clinical Efficacy and Toxicity of Anti-EGFR Therapy in Common CancersAmir Harandi, Aisha S Zaidi, Abigail M Stocker, et al.Pageof 264